mRNA is the next big thing in medicine. Here’s why Noxopharm could be the ASX front runner in this field“And that’s actually the basis of the Nobel Prize in medicine that was just awarded. The two scientists showed how can you give mRNA without creating these inflammatory side effects.
“That technology, no surprises, has been licensed to Moderna and Pfizer/BioNTech, and is therefore off the market.
“So, we at Noxpharm developed the same thing but with different approach to tackle the same problem. SOF-VAC basically aims to block the inflammatory receptors right at the source,” Mauter said.
https://unauthorised investment advice/health/mrna-is-the-next-big-thing-in-medicine-heres-why-noxopharm-could-be-the-asx-front-runner-in-this-field/
Ann: mRNA Vaccine Enhancer Shows Inflammation Reduction, page-16
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.37M | |||
| Open | High | Low | Value | Volume |
| 7.9¢ | 8.0¢ | 7.9¢ | $4.146K | 51.97K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 79733 | 7.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 148300 | 2 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.9¢ |
Change
0.000 ( 1.28 %) |
||||
| Open | High | Low | Volume | ||
| 7.9¢ | 7.9¢ | 7.9¢ | 2000 | ||
| Last updated 14.36pm 31/05/2024 ? | |||||
| NOX (ASX) Chart |